Pediatric Heart Transplant Outcomes Using Coronavirus Disease 2019-Positive Donors in the United States.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 42178087.
- Also identified by DOI 10.1016/j.athoracsur.2026.05.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Little is known about the impact of prior coronavirus disease 2019 (COVID-19) infection in an organ donor on the viability of the donor hearts in recipients less than 18 years of age. In a national cohort, we assess whether COVID-19+ donor status impacts outcomes after cardiac transplantation in recipients less than 18 years of age. We performed a retrospective review of the United Network for Organ Sharing databases of all heart transplant recipients less than 18 years of age, since the inception of COVID-19 data collection (April 2020-December 2024). A COVID-19+ donor was defined as "ever having a positive upper or lower respiratory SARS-CoV-2 nucleic acid amplification or antigen test within 21 days of Recovery." We used a nearest neighbor 1:1 propensity score match to adjust for differences between recipients of COVID-19+ and non-COVID-19+ donor hearts. Among 2245 pediatric heart transplants, 100 (4.5%) used COVID-19+ donor hearts. These recipients had lower body mass index (16.8 vs 17.8 kg/m<sup>2</sup>, P = .02), but were otherwise similar in age (6 vs 8 years, P = .09) and congenital heart disease prevalence (53% vs 51.5%, P = .85). In matched analyses of COVID-19+ vs non-COVID-19+, rates of postoperative stroke (1% vs 5%, P = .22), dialysis (8% vs 6%, P = .78), and acute rejection (9% vs 14%, P = .39) did not differ between groups. COVID-19 was not reported as a cause of death in any patients who died with a transplanted COVID-19+ heart. Survival at 1 year after transplant was 91.9% (95% CI, 86.2%-97.9%) for COVID-19+ donors and 93.2% (95% CI 88.1%-98.6%) for non-COVID-19+ donors (log-rank P = .71). COVID-19+ donor status was not associated with increased 1-year mortality (odds ratio, 0.88; 95% CI, 0.36-1.85; P = .76). Recipients of heart transplants less than 18 years of age from COVID-19+ donors demonstrated outcomes comparable to recipients of heart transplants less than 18 years of age from non-COVID-19+ donors. These findings support the safe use of COVID-19+ donor hearts in recipients less than 18 years of age, although longer follow-up is needed.